Picture of Scandinavian ChemoTech AB logo

CMOTEC B Scandinavian ChemoTech AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Scandinavian Chemotech Resolves On A Rights Issue Of About Sek 14.85 Mln

Oct 9 (Reuters) - Scandinavian ChemoTech AB
 CMOTECb.ST :
    * RESOLVES ON A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK
14.85
MILLION
    * SUBSCRIPTION PRICE AT SEK 2.50 PER B-SHARE
    * SUBSCRIPTION COMMITMENTS AMOUNT TO APPROXIMATELY SEK 6
MILLION,
CORRESPONDING TO APPROXIMATELY 40% OF THE RIGHTS ISSUE
    * SUBSCRIPTION PERIOD IN THE RIGHTS ISSUE RUNS FROM 18
OCTOBER
2023 UP TO AND INCLUDING 8 NOVEMBER 2023

Source text for Eikon:  ID:nWkr6ykQqm 
Further company coverage:  CMOTECb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Scandinavian ChemoTech AB

See all news